Dolutegravir Sodium: Potent Antiviral Raw Material for HIV Treatment and Prevention
A key component in modern HIV management, offering high efficacy and a favorable safety profile.
Get a Quote & SampleProduct Core Value

Dolutegravir Sodium
Dolutegravir Sodium is a vital raw material in the fight against HIV, functioning as an integrase chain transfer inhibitor (INSTI). Its primary mechanism involves inhibiting the human immunodeficiency virus (HIV) integrase, thereby preventing the integration of viral DNA into the host cell genome and fundamentally halting HIV replication. This active pharmaceutical ingredient (API) is recognized for its high efficiency, low propensity for drug resistance, stable chemical structure, and rapid absorption post-administration, allowing it to quickly achieve therapeutic concentrations.
- Discover the mechanism of integrase inhibitor drugs with Dolutegravir Sodium's action against HIV integrase.
- Explore why buy Dolutegravir Sodium online is a crucial step for developing advanced HIV treatment therapies.
- Understand the significance of Dolutegravir Sodium purity >99% for pharmaceutical applications.
- Learn about Dolutegravir Sodium GMP certification, ensuring quality and safety in its production.
Key Advantages
High Efficacy & Low Resistance
Dolutegravir Sodium offers exceptional efficacy in combating HIV, coupled with a low risk of developing drug resistance, making it a preferred choice in antiviral therapy.
Rapid Absorption & Bioavailability
The stable chemical structure ensures rapid absorption after oral administration, allowing the drug to reach effective therapeutic concentrations quickly, aiding patients in managing their condition.
Broad Application in HIV Management
From first-line treatment for adults and children to salvage therapy for drug-resistant strains and crucial roles in Dolutegravir Sodium PrEP and Dolutegravir Sodium PEP, its versatility is a major advantage.
Key Applications
HIV Treatment
As a core drug in first-line antiviral treatment for adults and children, and in salvage therapy for drug-resistant patients, Dolutegravir Sodium is fundamental to current HIV treatment protocols.
HIV Prevention (PrEP/PEP)
The efficacy and safety profile of Dolutegravir Sodium make it an important option for pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to reduce HIV infection risk.
Pharmaceutical Intermediate
This raw material is a critical intermediate in the synthesis of various antiretroviral drugs, contributing to ongoing pharmaceutical intermediate for antiretrovirals research.
Research & Development
Used in research settings to explore new antiviral therapies and understand the complex mechanisms of HIV replication, supporting advanced HIV therapeutics development.